In the murine model of T2D, inhibition of SIRT6 for ten days resulted in over-expression of muscular GLUT-1 and GLUT-4, enhanced glycolysis, decreased serum insulin as well as blood lipid concentrations and improved oral glucose tolerance [49]. Here, SIRT6 is linked to type 2 diabetes mellitus.